Open AccessLetter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal?
Author(s) -
Vasilios G. Athyros,
Niki Katsiki,
Dimitri P. Mikhailidis
Publication year - 2017
Publication title -
ajp gastrointestinal and liver physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.644
H-Index - 169
eISSN - 1522-1547
pISSN - 0193-1857
DOI - 10.1152/ajpgi.00101.2017
Subject(s) - nonalcoholic fatty liver disease , medicine , hydroxymethylglutaryl coa reductase inhibitors , statin , nonalcoholic steatohepatitis , gastroenterology , fatty liver , disease
in a recent issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology , Schierwagen et al. ([8][1]) reviewed the outcomes of statins on liver and cardiovascular disease (CVD) ([8][1]). A few comments might be of interest.In 2010, our post hoc analysis of the GREek
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom